Literature DB >> 28122964

Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7/8 to Polarized Macrophages and Fibrocytes.

Banishree Saha1, Karen Kodys1, Adeyinka Adejumo1, Gyongyi Szabo2.   

Abstract

Monocytes and macrophages (MΦs) play a central role in the pathogenesis of chronic hepatitis C virus (HCV) infection. The tissue microenvironment triggers monocyte differentiation into MΦs, with polarization ranging within the spectrum of M1 (classical) to M2 (alternative) activation. Recently, we demonstrated that HCV infection leads to monocyte differentiation into polarized MΦs that mediate stellate cell activation via TGF-β. In this study, we aimed to identify the viral factor(s) that mediate monocyte-to-MΦ differentiation. We performed coculture experiments using healthy monocytes with exosome-packaged HCV, cell-free HCV, or HCV ssRNA. Coculture of monocytes with exosome-packaged HCV, cell-free HCV, or HCV ssRNA induced differentiation into MΦs with high M2 surface marker expression and production of pro- and anti-inflammatory cytokines. The HCV ssRNA-induced monocyte activation and differentiation into MΦs could be prevented by TLR7 or TLR8 knockdown. Furthermore, TLR7 or TLR8 stimulation, independent of HCV, caused monocyte differentiation and M2 MΦ polarization. In vivo, in chronic HCV-infected patients, we found increased expression of TLR7/8 in circulating monocytes that was associated with increased intracellular expression of procollagen. Furthermore, knockdown of TLR8 completely attenuated collagen expression in monocytes exposed to HCV, and knockdown of TLR7 partially attenuated this expression, suggesting roles for TLR7/8 in induction of fibrocytes in HCV infection. We identified TLR7/8 as mediators of monocyte differentiation and M2 MΦ polarization during HCV infection. Further, we demonstrated that HCV ssRNA and other TLR7/8 ligands promote MΦ polarization and generation of circulating fibrocytes.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28122964      PMCID: PMC5322233          DOI: 10.4049/jimmunol.1600797

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.

Authors:  Heidi Barth; Jolanta Rybczynska; Romuald Patient; Youkyung Choi; Ronda K Sapp; Thomas F Baumert; Kris Krawczynski; T Jake Liang
Journal:  Hepatology       Date:  2011-08-11       Impact factor: 17.425

2.  Epigenetic regulation of tumor necrosis factor α (TNFα) release in human macrophages by HIV-1 single-stranded RNA (ssRNA) is dependent on TLR8 signaling.

Authors:  Xinbing Han; Xin Li; Simon C Yue; Asha Anandaiah; Falah Hashem; Peter S Reinach; Henry Koziel; Souvenir D Tachado
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

Review 3.  Innate immune cell networking in hepatitis C virus infection.

Authors:  Banishree Saha; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

4.  Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.

Authors:  Marlène Dreux; Urtzi Garaigorta; Bryan Boyd; Elodie Décembre; Josan Chung; Christina Whitten-Bauer; Stefan Wieland; Francis V Chisari
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

5.  Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

Authors:  Shuye Zhang; Karen Kodys; Kui Li; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2012-10-23       Impact factor: 22.682

6.  Global distribution and prevalence of hepatitis C virus genotypes.

Authors:  Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

Review 7.  Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.

Authors:  Leslie Chávez-Galán; Maria L Olleros; Dominique Vesin; Irene Garcia
Journal:  Front Immunol       Date:  2015-05-26       Impact factor: 7.561

8.  Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90.

Authors:  Terence N Bukong; Fatemeh Momen-Heravi; Karen Kodys; Shashi Bala; Gyongyi Szabo
Journal:  PLoS Pathog       Date:  2014-10-02       Impact factor: 6.823

9.  HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon.

Authors:  Michael A Chattergoon; Rachel Latanich; Jeffrey Quinn; Matthew E Winter; Robert W Buckheit; Joel N Blankson; Drew Pardoll; Andrea L Cox
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  17 in total

1.  Hepatitis C Virus Alters Macrophage Cholesterol Metabolism Through Interaction with Scavenger Receptors.

Authors:  Lucas T Jennelle; Tshifhiwa Magoro; Angelina R Angelucci; Aditya Dandekar; Young S Hahn
Journal:  Viral Immunol       Date:  2022-04       Impact factor: 2.175

Review 2.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

3.  HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells.

Authors:  Jinhee Hyun; Robert S McMahon; Anna L Lang; Jasmine S Edwards; Alejandro Dmitar Badilla; Morgan E Greene; Geoffrey W Stone; Suresh Pallikkuth; Mario Stevenson; Derek M Dykxhoorn; Shyam Kottilil; Savita Pahwa; Emmanuel Thomas
Journal:  PLoS Pathog       Date:  2019-07-01       Impact factor: 6.823

Review 4.  The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses.

Authors:  Flavia Giannessi; Alessandra Aiello; Francesca Franchi; Zulema Antonia Percario; Elisabetta Affabris
Journal:  Viruses       Date:  2020-05-22       Impact factor: 5.048

Review 5.  Extracellular Vesicles in Viral Infections of the Nervous System.

Authors:  Naseer A Kutchy; Eric S Peeples; Susmita Sil; Ke Liao; Ernest T Chivero; Guoku Hu; Shilpa Buch
Journal:  Viruses       Date:  2020-06-28       Impact factor: 5.048

Review 6.  A Review of Macrophage MicroRNAs' Role in Human Asthma.

Authors:  Gavriela Feketea; Corina I Bocsan; Cristian Popescu; Mihaela Gaman; Luminita A Stanciu; Mihnea T Zdrenghea
Journal:  Cells       Date:  2019-05-08       Impact factor: 6.600

7.  The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA-Containing Exosomes by HCV-Infected Hepatocytes.

Authors:  Ok-Kyung Kim; Da-Eun Nam; Young S Hahn
Journal:  Hepatology       Date:  2021-08-30       Impact factor: 17.425

Review 8.  Exosomes in Pathogen Infections: A Bridge to Deliver Molecules and Link Functions.

Authors:  Wenchao Zhang; Xiaofeng Jiang; Jinghui Bao; Yi Wang; Huixing Liu; Lijun Tang
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

9.  Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes.

Authors:  Tine Tesovnik; Jernej Kovač; Katka Pohar; Samo Hudoklin; Klemen Dovč; Nataša Bratina; Katarina Trebušak Podkrajšek; Maruša Debeljak; Peter Veranič; Emanuele Bosi; Lorenzo Piemonti; Alojz Ihan; Tadej Battelino
Journal:  Front Cell Dev Biol       Date:  2020-03-31

10.  Modular bioinformatics analysis demonstrates that a Toll‑like receptor signaling pathway is involved in the regulation of macrophage polarization.

Authors:  Biao Ma; Yang Yang; Zhituo Li; Dali Zhao; Weihui Zhang; Yanfeng Jiang; Dongbo Xue
Journal:  Mol Med Rep       Date:  2018-09-14       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.